Invenomic Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001769456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q4 2024 · 159 positions · Total reported value $2.10B · Top-10 concentration 31.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.9% · 35 new · 31 cut · 35 exited

Active Share (vs S&P 500): 99.0% · vs QQQ: 99.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.7% · vs SPY +0.6% · Prev Value $1.67B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +8.2% · vs SPY +6.1% · Latest Value $2.02B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, Invenomic Capital Management LP disclosed 159 equity positions with a combined reported value of $2.10B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 31.0% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q4 2024 were QQQ ($191.71M), SPY ($117.22M), GPN ($60.00M). By sector, the heaviest allocations are Consumer Discretionary 21.7%, Technology 16.7%. Versus the prior quarter, allocation shifted toward Other (+10.6pp), Utilities (+3.6pp) and away from Consumer Staples (-1.4pp), Health Care (-2.2pp).

Versus the prior quarter, Invenomic Capital Management LP opened 35 new positions, trimmed 31 and fully exited 35, a turnover rate of 66.9% of positions. The portfolio's overlap with the prior quarter was 63% of names.

The largest new positions opened in Q4 2024 were QQQ ($191.71M), SPY ($117.22M), PLD ($21.98M).

Of the 35 positions fully exited versus the prior quarter, the largest were WBD ($23.64M), EXE ($12.74M), FVRR ($12.40M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • QQQ INVESCO QQQ TR · $191.71M
  • SPY STATE STR SPDR S&P 500 ETF T · $117.22M
  • PLD PROLOGIS INC. · $21.98M
  • SLB SLB LIMITED · $17.61M
  • WEX WEX INC · $16.68M
  • VRNT VERINT SYS INC · $14.65M
  • INGM INGRAM MICRO HLDG CORP · $12.28M
  • AIN ALBANY INTL CORP · $11.58M

Fully Exited (vs previous quarter)

  • WBD WARNER BROS DISCOVERY INC · prev qtr: $23.64M
  • EXE EXPAND ENERGY CORPORATION · prev qtr: $12.74M
  • FVRR FIVERR INTL LTD · prev qtr: $12.40M
  • CRM SALESFORCE INC · prev qtr: $10.74M
  • AVA AVISTA CORP · prev qtr: $10.68M
  • COP CONOCOPHILLIPS · prev qtr: $9.77M
  • MD PEDIATRIX MEDICAL GROUP INC · prev qtr: $9.05M
  • SEDG SOLAREDGE TECHNOLOGIES INC · prev qtr: $8.49M

Insider Transactions (Form 4)

Latest Invenomic Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Invenomic Capital Management LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q3 2026 it reported 116 US equity positions with a combined value of $2.02B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-110459 (status: Approved), registered 2017-04-20
  • Regulatory AUM (Form ADV): $3.39B as of 2026-03-31
  • Client mix (by RAUM): registered investment companies 60%, pension and profit-sharing plans 40%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 116 positions · $2.02B reported value (Q3 2026)
  • Top 10 holdings = 29.4% of reported value
  • Largest position: UHS (UNIVERSAL HLTH SVCS INC) at 3.9%
  • Average position size: $17.43M

Sector Tilt

  • Consumer Discretionary 28.5%
  • Information Technology 26.1%
  • Industrials 14.9%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q3 2026: 35 new, 45 added, 31 reduced, 35 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 16.7%
Energy 5.6%
Utilities 3.6%
Other 32.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 375.00K $191.71M 9.12%
9.12%
New
2 200.00K $117.22M 5.58%
5.58%
New
3 535.45K $60.00M 2.85%
2.85%
Reduce
4 2.64M $50.09M 2.38%
2.38%
Add
5 849.70K $48.80M 2.32%
2.32%
Add
6 3.26M $40.59M 1.93%
1.93%
Reduce
7 652.12K $37.38M 1.78%
1.78%
Add
8 313.25K $36.62M 1.74%
1.74%
Add
9 1.11M $36.21M 1.72%
1.72%
Add
10 6.59M $33.46M 1.59%
1.59%
Add
11 666.43K $32.56M 1.55%
1.55%
Add
12 338.09K $32.34M 1.54%
1.54%
Add
13 1.32M $29.96M 1.43%
1.43%
Reduce
14 666.43K $28.84M 1.37%
1.37%
Add
15 1.04M $28.61M 1.36%
1.36%
Add
16 369.86K $28.03M 1.33%
1.33%
Reduce
17 1.62M $27.98M 1.33%
1.33%
Reduce
18 665.67K $26.96M 1.28%
1.28%
Reduce
19 2.05M $26.42M 1.26%
1.26%
Add
20 289.93K $23.66M 1.13%
1.13%
Reduce
21 222.40K $23.34M 1.11%
1.11%
Add
22 1.37M $22.97M 1.09%
1.09%
Reduce
23 1.81M $22.59M 1.07%
1.07%
Reduce
24 207.98K $21.98M 1.05%
1.05%
New
25 320.61K $21.18M 1.01%
1.01%
Reduce
26 1.22M $20.02M 0.95%
0.95%
Reduce
27 2.32M $19.69M 0.94%
0.94%
Reduce
28 989.76K $19.62M 0.93%
0.93%
Reduce
29 197.38K $19.37M 0.92%
0.92%
Reduce
30 601.49K $18.26M 0.87%
0.87%
Add
31 96.47K $18.14M 0.86%
0.86%
Reduce
32 2.17M $17.88M 0.85%
0.85%
Reduce
33 459.44K $17.61M 0.84%
0.84%
New
34 565.42K $17.36M 0.83%
0.83%
Reduce
35 614.91K $17.36M 0.83%
0.83%
Add
36 95.12K $16.68M 0.79%
0.79%
New
37 522.72K $15.82M 0.75%
0.75%
Add
38 341.84K $15.68M 0.75%
0.75%
Reduce
39 900.04K $15.24M 0.72%
0.72%
Add
40 356.76K $14.86M 0.71%
0.71%
Add
41 995.85K $14.81M 0.70%
0.70%
Reduce
42 533.83K $14.65M 0.70%
0.70%
New
43 1.04M $14.58M 0.69%
0.69%
Hold
44 351.97K $14.58M 0.69%
0.69%
Add
45 1.52M $14.56M 0.69%
0.69%
Add
46 5.19M $13.85M 0.66%
0.66%
Reduce
47 69.10K $12.88M 0.61%
0.61%
Reduce
48 149.84K $12.79M 0.61%
0.61%
Reduce
49 2.02M $12.42M 0.59%
0.59%
Reduce
50 633.51K $12.28M 0.58%
0.58%
New

FAQ

What did Invenomic Capital Management LP buy in 2024-Q4?

In its 2024-Q4 13F filing, Invenomic Capital Management LP reported 159 equity positions worth $2.10B in aggregate; its largest disclosed positions were QQQ ($191.71M), SPY ($117.22M), GPN ($60.00M).

How large is Invenomic Capital Management LP's portfolio?

Invenomic Capital Management LP reported $2.10B of long equity holdings across 159 positions as of 2024-Q4. Top-10 holdings account for 31.0% of reported value.

What is Invenomic Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/invenomic-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →